Neurology CME

Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
July 15, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
R. Robert Auger, MD, FAASM, FAPA, DABPN
June 25, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Managing Motor Complications in Parkinson’s Disease: Evaluating the Role of On-Demand Therapies for “Off” Episodes
Stuart H. Isaacson, MD
June 22, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
Loren D.M. Pena, MD, PhD
June 10, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
Jinsy A. Andrews, MD, MSc, FAAN
June 8, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
Richard K. Bogan, MD, FCCP, FAASM
May 18, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
The Rise of B-Cell Therapies in Relapsing MS: Examining the State of the Science, New Therapeutic Options, and Patient-Centered Clinical Decision-Making
Ludwig Kappos, MD, FEAN, FAAN
May 4, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS
May 3, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
Elizabeth A. Thiele, MD, PhD
April 14, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
Crystal M. Proud, MD
March 30, 2021
Credits: 0.50 CME
Penn State College of Medicine
A Visual Guide to B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape
Edward J. Fox, MD, PhD
March 26, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
Marwan Sabbagh, MD, FAAN, CCRI
March 22, 2021
Credits: 1.00 CME / NCPD / CPE
Medical Learning Institute, Inc.
Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
Anne H. Cross, MD, FAAN / Prof. Xavier Montalban
February 1, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
Maria K. Houtchens, MD, MMs
January 22, 2021
Credits: 0.25 CME
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
Bruce Cree, MD, PhD, MAS
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
John Ravits, MD
December 31, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Rethinking Glioblastoma Care in an Evolving Therapeutic Landscape: Expert Perspectives on Modern Modalities, Novel Agents, and Combinations
Steven Brem, MD
December 29, 2020
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
Bruce R. Korf, MD, PhD
December 18, 2020
Credits: 1.00 CME
PeerView Institute
Improving Recognition of Nonvalvular Atrial Fibrillation to Reduce the Risk of Preventable Stroke: A Visual Guide for Clinicians
Sean Pokorney, MD, MBA
December 3, 2020
Credits: 1.00 CME
PeerView Institute
Advances in the Treatment of Alzheimer’s Disease: Preparing for a Shift in the Treatment Paradigm
Richard S. Isaacson, MD, FAAN
November 24, 2020
Credits: 0.50 CME
Johns Hopkins University School of Medicine
Not So FAST: Improving the Diagnosis and Treatment of Posterior Circulation Stroke
Victor C. Urrutia, MD, FAHA
November 13, 2020
Credits: 1.50 CME / CPE
Purdue University College of Pharmacy
Cannabidiol in the Treatment Arsenal for Severe Epilepsy Syndromes: Practical Guidance for Managed Care Professionals
Orrin Devinsky, MD / Sheldon J. Rich, RPh, PhD
November 13, 2020
Credits: 1.00 CME
PeerView Institute
Progressive Pathways: Recent Recommendations and Emerging Therapies for Treating NF1-Associated Tumors
Roger J. Packer, MD
November 5, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Realizing the Full Clinical Potential of Sphingosine-1-Phosphate Receptor Modulation to Improve Outcomes in Patients With Multiple Sclerosis
Amit Bar-Or, MD, FRCPC / Bruce Cree, MD, PhD, MAS
October 30, 2020
Credits: 1.00 CME
Penn State College of Medicine
What’s New in Relapsing MS? Expert Perspectives on Pathogenesis, Targeting B Cells for Treatment, and Advances in Disease-State Monitoring
Prof. Xavier Montalban
October 29, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Addressing Unmet Needs in the Acute Treatment of Migraine: Focus on the Role of the 5-HT1F Receptor
Peter Goadsby, MD, PhD
October 21, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Finding the Path to Improved Recognition and Management of Tardive Dyskinesia
Karen Elta Anderson, MD
September 28, 2020
Credits: 1.25 CME / CNE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving Patient Outcomes With an Innovative Therapeutic Approach
Concetta (Connie) DiDomenico, RN, MSN, PNP-BC, CPHON / Michael J. Fisher, MD
September 24, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Exploring Current Guidelines and Emerging Therapeutic Strategies for the Treatment of Dementia-Related Psychosis
Marwan Sabbagh, MD, FAAN, CCRI
September 15, 2020
Credits: 1.00 CME
Johns Hopkins University School of Medicine
Time Is of The Essence: Incorporating Recent Guideline Updates to Support Early Recognition and Management of Acute Ischemic Stroke
Victor C. Urrutia, MD, FAHA
September 14, 2020

Pages

Education Collections